The Role of Notch Signaling Pathway in the Progression of Pancreatic Cancer


Introduction

Pancreatic cancer (PC) is a highly aggressive malignancy and ranks as the fourth leading cause of cancer-related death in the United States . This high mortality is partly due to the absence of specific symptoms and signs, and the lack of early detection tests for PC, as well as the lack of effective chemotherapies . Although the molecular mechanisms of PC development remain largely unclear, many factors have been reported to be associated with increased incidence of PC . For example, a history of diabetes or chronic pancreatitis, chronic cirrhosis, a family history of PC, a high-fat and high-cholesterol diet, tobacco smoking, alcohol and coffee intake, and specific blood type have been found to contribute to PC development . Accumulated evidence has demonstrated that many key genes and cell signaling pathways also play critical roles in pancreatic tumorigenesis . Recently, some studies have demonstrated that the Notch signaling pathway contributes to PC development and progression . Therefore, in the following sections, we will discuss the roles of the Notch signaling pathway in the regulation of cell proliferation, apoptosis, migration, invasion, metastasis, angiogenesis, drug resistance, epithelial-to-mesenchymal transition (EMT), and cancer stem cell (CSC) functions in PC.

Notch Signaling Pathway

It has been well documented that the Notch signaling pathway plays critical mechanistic roles in the development of organs, tissue proliferation, differentiation, and apoptosis . It is known that mammals express four transmembrane Notch receptors (Notch-1, Notch-2, Notch-3, and Notch-4) and five canonical transmembrane ligands (Delta-like 1, Delta-like 3, Delta-like 4, Jagged-1, and Jagged-2) . All four Notch receptors are very similar, although they have subtle differences in their extracellular and cytoplasmic domains ( Figure 4.1 ). The extracellular domains of the Notch proteins possess multiple repeats that are related to epidermal growth factor (EGF) and are thought to participate in ligand binding. The amino-terminal EGF-like repeats are followed by a cysteine-rich region termed the LNR (LIN-12/Notch-related region), which prevents signaling when a ligand is absent . The cytoplasmic region of the Notch conveys the signal to the nucleus; it contains a recombination signal-binding protein 1 for J-kappa (RBP-J)-association molecule (RAM) domain, ankyrin (ANK) repeats, nuclear localization signals (NLS), a transactivation domain (TAD), and a region rich in proline, glutamine, serine, and threonine residues (PEST) sequences . Notch ligands have multiple EGF-like repeats in their extracellular domain and a cysteine-rich region (CR) in serrate which are absent in delta .

Figure 4.1, Structure of Notch Receptors (1–4) and Ligands (Jagged-1, 2, Dll-1, 3, Four).

The Notch signaling pathway is activated after Notch-ligand binding followed by three consecutive proteolytic cleavages by multiple enzyme complexes including γ-secretase complex . This produces an active fragment, the Notch intracellular domain (NICD), which enters the nucleus and binds to CSL, displaces corepressors from CSL, and subsequently recruits a coactivator complex containing mastermind, p300, and other coactivators, leading to the activation of Notch target genes . So far, many Notch target genes have been identified such as hairy enhance of split (Hes) family, Hey family, Akt, cyclin D1, c-myc, cyclooxygenase-2 (COX-2), extracellular signal-regulated kinase (ERK), matrix metalloproteinase-9 (MMP-9), mammalian target of rapamycin (mTOR), nuclear factor-kappa B (NF-κB), p21, p27, p53, and vascular endothelial growth factor (VEGF) . Since these target genes are critically involved in tumorigenesis, the Notch signaling pathway plays a pivotal role in the development and progression of human cancers including PC via regulating its target genes .

The Role of Notch in PC

It is worth mentioning that the function of Notch signaling in tumorigenesis can be either oncogenic or oncosuppressive, suggesting that its function is context dependent to some extent . For example, one study has shown that Notch-1 has an oncosuppressive function in skin cancer . In contrast, most studies have revealed that Notch activation is oncogenic in a variety of human cancers including PC . In the following paragraphs, we will discuss how the Notch signaling pathway is involved in the development and progression of PC.

Notch is Overexpressed in PC

Aberrant Notch pathway activation has been implicated in the initiation and progression of PC . For instance, Miyamoto et al. reported that Notch pathway components and Notch target genes are upregulated in invasive human PC . Consistently, Terris et al. found that the Notch gene was highly expressed in human PC . Similarly, Fukushima et al. also reported that Jagged-1 and Hes-1 were overexpressed in PC . In line with this, Cavard et al. showed that members of the Notch pathway (Hey-1, Hey-2, Notch-2) were also upregulated in PC . To further support the oncogenic role of Notch in PC, Büchler et al. found that Notch-3 and Notch-4 expressed at higher levels in human PC tissues compared with normal pancreatic tissue . They also found that Jagged-1, Jagged-2 and Dll-1 were significantly upregulated in PC tissue specimens . In agreement with these findings, overexpression of Jagged-2 and Dll-4 has been reported in the vast majority of PC cell lines . All of these reports clearly suggest the possible link between Notch gene overexpression and PC.

Notch Promotes Cell Growth in PC

Studies have demonstrated that Notch regulates cell proliferation in human cancers including PC. Our previously studies have documented the role of Notch-1 in controlling cell growth in PC . Using MTT assay, we found that downregulation of Notch-1 expression by its siRNA caused cell growth inhibition in PC cell lines. Moreover, overexpression of Notch-1 by its cDNA transfection promoted cell growth in PC cells . To further support the role of Notch signaling pathway, one study has shown that blockade of delta-like ligand four inhibited tumor growth of pancreatic cancer . Similarly, the suppression of Notch-3 expression inhibited cell growth in PC cells . Moreover, genetic and pharmacologic inhibition of Notch signaling mitigated anchorage-independent growth in PC cells . For example, MRK-003, a potent and selective γ-secretase inhibitor, treatment led to the downregulation of nuclear NICD and inhibition of anchorage-independent PC cell growth . Treatment of PC cells with MRK-003 in cell culture significantly inhibited the subsequent engraftment in immunocompromised mice. Furthermore, MRK-003 treatment significantly blocked tumor growth in PC xenografts . Mechanistically, it has been revealed that activation of Notch-mediated cell growth may be mediated in part through the activation of NF-κB activity . Taken together, the Notch signaling pathway that promotes tumor cell growth in PC is a scientific fact.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here